Founder and Chief Medical Executive
Miami Cardiac & Vascular Institute
Q. What do you think the future of cardiovascular care looks like? I’m very excited about the future. I see the path in cardiac and vascular change accelerating and continuing to grow in a very significant way in the direction of minimally invasive therapy. Some people believe surgery will be gone and that no one will be performing surgery anymore and that we won’t need surgeons. But that’s not true. We need vascular surgeons more than ever. I think we will continue to need all aspects of the multidisciplinary team. We want to take the most severe, the worst cardiac disease, the worst aneurysm disease, the worst cardiovascular problem you can have, and treat that as an outpatient and send those patients home. That’s where we want to go. Q. How close are we now to treating patients at home? I can see the day where a patient can come in, have an aortic valve replaced, have an aneurism repair done, then go home in 2 or 3 days, they generally have reached full recovery by the period of 2 to maybe 3 weeks, and are back to normal activity. It is our goal to take everything that can occur in the cardiovascular system, be able to treat it in the least invasive way, the most effective, cost-effective way, and get these patients back as quickly as possible. Q. How much of a big leap forward has this been for cardiovascular care? Q. Does that give Miami Cardiac & Vascular Institute a greater role in preventative care? Q. What advice would you give your peers based on your 30 years leading Miami Cardiac & Vascular Institute?
Five years ago, I was speaking to our foundation about how we imagined this in the future and I said something like ‘Can you imagine one day where we treat a patient with an aortic aneurism and they go home the same day?’ This is a procedure that, 10 or 15 years ago would have required 5 days in the ICU, 7 days in the hospital and 30 days of recovery.
One of the real advantages of this revolution in cardiac and vascular care has been our ability to treat patients that were not treatable in the past, that were too sick to be treated. They couldn’t tolerate open surgery, and now we can also get them home in very rapid fashion. Something like 85% of the work that’s done here at the Institute is done on an outpatient basis, in fact. We have a number of goals around therapeutic innovation, and our goal is to take specific diseases and make them treatable as an outpatient such as aneurisms. We hope, one day, to have most of our patients who suffer from aneurism disease be able to be treated and go home the same day. That’s one of the goals around the innovation that we’re trying to apply here at Miami Cardiac & Vascular Institute.
It’s part of our responsibility to prevent disease and not just focus on treatment of disease. We are spending considerable efforts in our communities to deal with those patients who are 20 years old - patients who aren’t yet patients - and trying to prevent the devastating effects of cardiovascular disease in the older ages.
Well, if I had to give someone any type of advice about decision-making, and we make decisions in all different areas, clinical decisions, equipment purchasing decisions, management decisions, it’s always about the future. It’s not about the present. If you make decisions based only on the present, you’ll never be prepared for the future.
A customer story from Miami Cardiac & Vascular Institute
Founder and Chief Medical Executive Miami Cardiac & Vascular Institute
Barry T. Katzen, M.D.
There's always a way to make life better.
DISCLAIMER: Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
You are about to visit a Philips global content page
ContinueThe information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.